This program will discuss key clinical trial findings presented at the American 
College of Cardiology’s 2023 scientific sessions. The program format will engage participants in an interactive discussion regarding trial results and implications, and will focus in these topic areas:
Lipids/prevention
Inflammation
Heart failure
Hypertension
Trials for discussion will include:
 CLEAR-Outcomes
 Oral PCSK9 inhibitors and other new 
 lipid compounds

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from:

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program is available for CCRN members from the CCRN website at www.ccrnmd.com/resources